Breaking News Instant updates and real-time market news.

GOOGL

Alphabet Class A

$1,263.27

17.33 (1.39%)

, AMZN

Amazon.com

$1,973.87

40.955 (2.12%)

12:06
08/29/18
08/29
12:06
08/29/18
12:06

Fly Intel: Wall Street's top stories at midday

Stocks opened little changed but drifted higher throughout the morning. In the process, the S&P and Nasdaq hit new highs and the Dow has crept closer to one. The strength is being attributed to optimism over trade talks with Canada and a confirmation earlier in the day that GDP grew at over a 4% rate in the second quarter. ECONOMIC EVENTS: In the U.S., Q2 GDP was revised up to a 4.2% growth rate from 4.1% in the advance report, which was better than the projected tick down to a 4.0% rate. An index of pending home sales dipped 0.7% to 106.2 in July, which was a little weaker than forecast. COMPANY NEWS: Shares of Google parent Alphabet (GOOGL) and Amazon (AMZN) have advanced, helping the Nasdaq be the leader among the major averages, after Morgan Stanley analyst Brian Nowak raised his price targets for the stocks to $1,515 and $2,500, respectively. In addition to the high price targets, both companies have been in the spotlight after Senator Bernie Sanders accused the e-commerce giant of not paying its lower-level employees a fair wage and as President Trump slammed the search titan's service as "rigged"... In additional Amazon news, shares of Roku (ROKU) have been under pressure after The Information reported that an Amazon subsidiary is working on a free, ad-supported streaming service that sounds similar to what Roku is doing with The Roku Channel. MAJOR MOVERS: Among the noteworthy gainers was Glaukos (GKOS), which surged 35% after Novartis' (NVS) Alcon unit withdrew the CyPass micro-stent from the market due to safety concerns. Also higher was Tilray (TLRY), which gained 19% after reporting quarterly results. Among the notable losers was Assertio Therapeutics (ASRT), which slipped 12% after it disclosed a patent infringement suit settlement agreement with Purdue Pharma. Also lower were Movado (MOV) and Dick's Sporting Goods (DKS), which fell a respective 15% and 5% after reporting quarterly results. INDEXES: Near midday, the Dow was up 78.92, or 0.30%, to 26,142.94, the Nasdaq was up 62.75, or 0.78%, to 8,092.79, and the S&P 500 was up 14.97, or 0.52%, to 2,912.49.

GOOGL

Alphabet Class A

$1,263.27

17.33 (1.39%)

AMZN

Amazon.com

$1,973.87

40.955 (2.12%)

ROKU

Roku

$61.28

-1.71 (-2.71%)

GKOS

Glaukos

$60.11

15.32 (34.20%)

NVS

Novartis

$83.75

-0.03 (-0.04%)

TLRY

Tilray

$61.50

10.24 (19.98%)

ASRT

Assertio Therapeutics

$6.48

-0.85 (-11.60%)

MOV

Movado

$41.95

-7.4 (-14.99%)

DKS

Dick's Sporting

$34.08

-2.31 (-6.35%)

GOOG

Alphabet

$1,246.81

15.33 (1.24%)

  • 29

    Aug

  • 29

    Aug

  • 29

    Aug

  • 05

    Sep

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

GOOGL Alphabet Class A
$1,263.27

17.33 (1.39%)

08/22/18
MKMP
08/22/18
NO CHANGE
Target $1465
MKMP
Buy
Alphabet price target raised to $1,465 from $1,355 at MKM Partners
MKM Partners analyst Rob Sanderson raised his price target on Alphabet to $1,465 from $1,355 and kept his Buy rating, saying his revision removes the $5.1B E.U. fine while rolling out the valuation to 2021 in his model. Sanderson states that he remains impressed with Alphabet's "consistent growth at increasingly large revenue levels" and believes that the company's traffic acquisition costs could slow after a drag on earnings over a period of about 3 years, boosting its margins. The analyst adds that while Waymo has "negligible" near-term implications, its long-term potential is "tremendous".
08/09/18
STFL
08/09/18
DOWNGRADE
Target $2150
STFL
Hold
Booking Holdings downgraded to Hold on slowing growth at Stifel
As previously reported, Stifel analyst Scott Devitt downgraded Booking Holdings (BKNG) to Hold from Buy, citing the slowing growth at the company-formerly-known-as Priceline. Devitt lowered his core bookings growth expectations in 2018 and beyond following the company's Q2 earnings report and cut his price target on Booking shares to $2,150 from $2,332. He sees better large cap opportunities at company's with similar earnings multiples and better growth, such as Alibaba (BABA), Alphabet (GOOGL) and Facebook (FB), Devitt added.
08/29/18
08/29/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MORGAN STANLEY RAISES ALPHABET, AMAZON TARGETS: Morgan Stanley analyst Brian Nowak raised his price target on shares of Alphabet (GOOGL) to $1,515 from $1,325 citing the continued strong fundamentals in its core Google business as well as the growing visibility into its Waymo business. Nowak, who raised his 2018 and 2019 adjusted EBITDA estimates by 2%, kept an Overweight rating on Alphabet shares. Additionally, Nowak expressed increasing confidence that Amazon's (AMZN) rapidly growing, high margin revenue streams will drive higher profitability and continue to push up consensus estimates. He has not made any changes to his estimates, but raised his price target on Amazon shares to $2,500 from $1,850 to reflect its improving business mix and his belief that the new target more accurately represents the company's long-term potential earnings power. He maintained an Overweight rating on Amazon shares. FERRARI UPGRADED TO BUY: HSBC analyst Giulio Pescatore upgraded Ferrari (RACE) to Buy and raised his price target for the shares to EUR 133 from EUR 114. The recent selloff on the CEO's comments regarding Sergio Marchionne's 2022 targets has provided an attractive entry point, Pescatore said. The analyst believes Ferrari's pipeline remains strong. ROYAL CARIBBEAN UPGRADED TO BUY: Deutsche Bank analyst Chris Woronka upgraded Royal Caribbean Cruises (RCL) to Buy and raised his price target for the shares to $146 from $135. The analyst finds the stock's valuation as "undemanding" at current share levels. Further, he sees the potential for more inflows into cruise stocks for the balance of 2018 as comps get tougher across sectors like lodging, retail, and Macau, but "relatively easier" for Royal Caribbean. JEFFERIES RAISES TARGET ON PAYPAL: Jefferies analyst John Hecht raised his price target for PayPal (PYPL) to $110 from $100 saying the company's growth story is more than just Venmo. While Venmo is an important growth driver, PayPal's core person-to-person business and mobile trends, which have been "impressive," should be followed more closely alongside the Venmo success, Hecht said. The analyst's updated analysis supports his belief that the eBay (EBAY) migration should be "very manageable" for PayPal. Further, his analysis of app downloads shows PayPal platforms "remain competitive." Hecht reiterated a Buy rating on the shares.
08/29/18
MSCO
08/29/18
NO CHANGE
Target $1515
MSCO
Overweight
Alphabet price target raised to $1,515 from $1,325 at Morgan Stanley
Morgan Stanley analyst Brian Nowak raised his price target on shares of Alphabet to $1,515 from $1,325 citing the continued strong fundamentals in its core Google business as well as the growing visibility into its Waymo business. Nowak believes the current valuation of Alphabet ascribes little value for Waymo, but he also thinks the launch of Waymo's ride-hailing service by year-end can be a catalyst to realize that value. He currently values Waymo at $45B, or about $60 per Alphabet share, but notes this is only 25% of the $175B potential value he ascribes to the business. Nowak, who raised his 2018 and 2019 adjusted EBITDA estimates by 2%, keeps an Overweight rating on Alphabet shares.
AMZN Amazon.com
$1,973.87

40.955 (2.12%)

08/29/18
JEFF
08/29/18
NO CHANGE
Target $40
JEFF
Buy
Tailored Brands shares now 'extremely cheap,' says Jefferies
Jefferies analyst Randal Konik says that while the CEO's retirement after recent share underperformance "doesn't look good optically and a preliminary 2Q comp would have helped," shares of Tailored Brands (TLRD) are "extremely cheap." Investors need to think through last night's release, Konik tells investors in a research note titled "Getting A New Tailor While Guidance Shows Biz Stable." Management changes can be good while Tailored is insulated from Amazon.com (AMZN) disintermediation and the job market and fashion trends provide upcoming catalysts, the analyst contends. He keeps a Buy rating on Tailored Brands with a $40 price target.
08/29/18
MSCO
08/29/18
NO CHANGE
Target $2500
MSCO
Overweight
Amazon price target raised to $2,500 from $1,850 at Morgan Stanley
Morgan Stanley analyst Brian Nowak expressed increasing confidence that Amazon's rapidly growing, high margin revenue streams - namely advertising, AWS, and subscriptions - will drive higher profitability and continue to push up consensus estimates. He has not made any changes to his estimates, but raised his price target on Amazon shares to $2,500 from $1,850 to reflect its improving business mix and his belief that the new target more accurately represents the company's long-term potential earnings power. In his new sum-of-the-parts model, Nowak values core retail at about $625B, values the AWS cloud business at roughly $375B, values Prime subscriber revenue at $100B and values the advertising business at $125B. He maintains an Overweight rating on Amazon shares, which closed yesterday at about $1,933 per share.
08/29/18
KEYB
08/29/18
NO CHANGE
KEYB
KeyBanc sees plenty of room for both Amazon, Roku given TV advertising TAM size
KeyBanc analyst Evan Wingren notes The Information has reported that Amazon's (AMZN) IMBD subsidiary is working on a free, ad-supported streaming service, which sounds similar to what Roku (ROKU) is doing with The Roku Channel. The analyst says he has long expected this to be part of Amazon's advertising strategy and that it would be announced at some point. Given the size of the TV advertising TAM that has not yet transitioned to streaming, Wingren sees "plenty of room for both companies to operate this strategy" for the foreseeable future and be successful. Overall, the analyst believes Amazon has the potential to create a very compelling value proposition to advertisers with good execution.
ROKU Roku
$61.28

-1.71 (-2.71%)

08/28/18
LOOP
08/28/18
NO CHANGE
Target $52
LOOP
Hold
Roku price target raised to $52 from $43 at Loop Capital
Loop Capital analyst Alan Gould raised his price target on Roku to $52 to reflect his higher multiple estimate of 6.5-times his expected 2019 revenues, up from 5.5-times prior forecast. The analyst cites the company's continued market share capture of connected TVs, even though it faces a "substantial potential competition". Gould keeps a Hold rating on Roku, adding that there has recently been a "large amount of insider selling", even though he continues to expect the company to beat its quarterly estimates.
08/09/18
WBLR
08/09/18
NO CHANGE
WBLR
Outperform
Roku shares have additional 20% upside, says William Blair
William Blair analyst Ralph Schackart says that at the post-earnings share price of $51, Roku shares have additional upside around 20%. As the traditional TV ad market transitions in favor of over-the-top and streamed video, Roku is well positioned to take advantage, Schackart tells investors in a post-earnings research note. He believes the Roku Channel is making "significant progress" and keeps an Outperform rating on the shares.
08/10/18
DADA
08/10/18
NO CHANGE
Target $44
DADA
Neutral
Roku price target raised to $44 from $32 at DA Davidson
DA Davidson analyst Tom Forte raised his price target on Roku to $44 after its Q2 results, with sales, EPS, and EBITDA all beating expectations. The analyst cites a 57% increase in usage - above his forecast of 50% - along with a 46% increase in active accounts and an average revenue per user increase of 40%. Forte also keeps his Neutral rating on Roku, noting that the current share price likely reflects its long-term growth prospects.
GKOS Glaukos
$60.11

15.32 (34.20%)

08/29/18
SPHN
08/29/18
NO CHANGE
Target $57
SPHN
Overweight
Glaukos price target raised to $57 at Stephens after Novartis withdraws CyPass
Stephens analyst Chris Cooley raised his price target on Glaukos (GKOS) shares to $57 from $50 after Novartis' (NVS) Alcon unit withdrew the CyPass micro-stent from the market due to safety concerns. He estimates $40M-$50M in annual sales are now "in play" and see Glaukos as the most likely beneficiary, Cooley tells investors. He maintains an Overweight rating on Glaukos shares, which are up $17.35, or 39%, to $62.15 in pre-market trading.
08/29/18
JPMS
08/29/18
UPGRADE
Target $75
JPMS
Overweight
JPMorgan upgrades Glaukos after 'main competitor' pulls product
As previously reported, JPMorgan analyst Robert Marcus upgraded Glaukos (GKOS) to Overweight from Neutral, calling Alcon's (NVS) voluntary withdrawal of its micro-stent from the market a "significant win" that opens up an opportunity for Glaukos to take back principally all of the sales being generated by CyPass. Stating that he's always been a firm believer in Glaukos' pipeline and technology, Marcus said competition had been the main factor keeping him on the sidelines. Now that its "main competitor" is out of the way, he sees Glaukos having a meaningful opportunity to recapture share and lead the market. Marcus raised his price target on the stock to $75 from $42.
08/29/18
JPMS
08/29/18
UPGRADE
JPMS
Overweight
Glaukos upgraded to Overweight from Neutral at JPMorgan
08/29/18
PIPR
08/29/18
NO CHANGE
Target $55
PIPR
Overweight
Piper sees CyPass withdrawal as 'major boon' for Glaukos, ups target to $55
Piper Jaffray analyst Matt O'Brien views Alcon's immediate withdrawal of its CyPass stent for the treatment of glaucoma on safety concerns from a recently completed clinical study as a "major boon" for Glaukos (GKOS). The analyst suspects it will be several quarters before CyPass comes back to the market, with with a much narrower indication. This is a "major positive" for Glaukos as most of the clinicians using CyPass had been or are still using iStent from Glaukos, O'Brien tells investors in a research note. He anticipates many clinicians will quickly shift their volumes back to iSten, yielding "significant incremental revenues." Based on this morning's news, the analyst raised his price target for Glaukos shares to $55 from $46. He encourages investors to start or build positions in the name.
NVS Novartis
$83.75

-0.03 (-0.04%)

08/29/18
WBLR
08/29/18
NO CHANGE
WBLR
Outperform
CyPass market removal a 'clear positive' for Glaukos, says William Blair
William Blair analyst Brian Weinstein believes Alcon's voluntary global market withdrawal of its CyPass Micro-Stent for surgical glaucoma is a "clear positive for near-term numbers" at Glaukos (GKOS). If Glaukos' iStent takes all of the CyPass market share while it is off the market, the company could add as much as $50M in the U.S. alone to its 2019 total revenue of around $186M, Weinstein tells investors in a research note, while admitting this is a bullish stance. The analyst thinks the news this morning from Alcon should be viewed as a positive for Glaukos, as a major part of the short thesis was on competition in the core iStent market, mainly from Alcon. He keeps an Outperform rating on Glaukos shares.
TLRY Tilray
$61.50

10.24 (19.98%)

08/27/18
COWN
08/27/18
NO CHANGE
Target $34
COWN
Outperform
Tilray remains well positioned in cannabis market, says Cowen
Cowen analyst Vivien Azer believes Tilray remains well positioned to benefit from a legal recreational cannabis market in Canada. She noted it is an emerging industry and is subject to regulatory headwinds and she believes much work is needed for the industry to reach its full potential. Azer reiterated her Outperform rating on Tilray shares with a price target of $34. Tilray shares closed at $43.86 on Friday and in pre-market trading are up nearly 15% to $50.34.
08/13/18
COWN
08/13/18
INITIATION
COWN
Outperform
Tilray initiated with an Outperform at Cowen
08/14/18
ROTH
08/14/18
INITIATION
Target $35
ROTH
Buy
Tilray initiated with a Buy at Roth Capital
Roth Capital analyst Charles Finnie started Tilray with a Buy rating and $35 price target. Although not the largest player, the company's unsurpassed product quality and cultivation expertise compare favorably to the leading Canadian Licensed Producers, he contends. The analyst expects revenues to grow at 40% plus annual rate over the next three to five years, with earnings growing considerably faster with expected operating margin expansion.
ASRT Assertio Therapeutics
$6.48

-0.85 (-11.60%)

08/29/18
JANY
08/29/18
DOWNGRADE
JANY
Neutral
Assertio Therapeutics downgraded to Neutral from Buy at Janney Montgomery Scott
MOV Movado
$41.95

-7.4 (-14.99%)

06/12/18
SIDC
06/12/18
DOWNGRADE
SIDC
Neutral
Movado downgraded to Neutral from Buy at Sidoti
08/22/18
SIDC
08/22/18
UPGRADE
SIDC
Buy
Movado upgraded to Buy from Neutral at Sidoti
DKS Dick's Sporting
$34.08

-2.31 (-6.35%)

08/29/18
BARD
08/29/18
NO CHANGE
Target $27
BARD
Outperform
Under Armour selloff on Dick's 'head fake' a buying opportunity, says Baird
Baird analyst Jonathan Komp noted that while Dick's Sporting Goods (DKS) reported its own "disappointing" earnings, the company called out continued sales challenges for Under Armour (UAA), which it attributed to expanded distribution. He believes current sporting goods disruption for Under Armour is already reflected in the company's 2018 earnings guidance and also believes other mid-tier channels have continued to show strong sales performance, pointing out that Kohl's (KSS) saw Under Armour accelerate in Q2. Komp, who views the selloff on Dick's comments a "compelling buying opportunity," keeps an Outperform rating and $27 price target on Under Armour Class A shares.
08/15/18
OTRG
08/15/18
UPGRADE
OTRG
Positive
Dick's Sporting upgraded to Positive following checks at OTR Global
OTR Global upgraded Dick's Sporting to Positive from Mixed following checks that indicate Q2 sales were aided by favorable weather, increased customer interest in branded products, and price-matching programs.
08/15/18
OTRG
08/15/18
UPGRADE
OTRG
Positive
Dick's Sporting upgraded to Positive from Mixed at OTR Global
08/20/18
SUSQ
08/20/18
NO CHANGE
SUSQ
Positive
Nervousness not necessary ahead of footwear retailers' results, says Susquehanna
Susquehanna analyst Sam Poser noted investors are very nervous regarding earnings of footwear retailers, but he sees little to no reason for such nervousness. The analyst believes Dick's Sporting (DKS), Foot Locker (FL), and Hibbett Sports (HIBB) are well positioned heading into earnings. The analyst said product assortment is improving, inventory levels are as clean as they have been in years, and based on forward weeks of supply, all three are at historic lows. Poser believes the combination of better product and clean inventory will provide a revenue and margin tailwind in Q2 and beyond. Poser has a Positive rating on Dick's Sporting, Foot Locker, and Hibbett Sports shares.
GOOG Alphabet
$1,246.81

15.33 (1.24%)

08/07/18
08/07/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS ZILLOW TO NEUTRAL: BofA Merrill Lynch analyst Nat Schindler downgraded Zillow (Z, ZG) to Neutral from Buy and cut its price target to $60 from $70 following the Q2 report and reduction in guidance. Schindler said the quarter indicated Zillow is taking longer than expected to ramp up the Homes business, Rentals revenue missed and the outlook was cut, and other revenue also missed, indicating the new construction opportunity is also taking longer to materialize. Zillow Class A shares are down about 17% in late morning trading. MORGAN STANLEY SAYS WAYMO COULD BE WORTH $175B: Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's (GOOG, GOOGL) Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares. GOLDMAN RAISES NVIDIA TARGET AHEAD OF EARNINGS: Goldman Sachs analyst Toshiya Hari raised his price target for Nvidia (NVDA) to $324 from $310 ahead of quarterly results. Unlike the past 10 quarters where the company handily beat Street estimates and raised guidance, the analyst expects a "noisy" quarter with the focal points being the upcoming product transition in Gaming, the current product transition in Datacenter, weakness in cryptocurrency mining, and potential disruption from the virus attack at TSMC (TSM). That said, Hari noted that his long-term bull thesis on Nvidia remains intact and reiterated a Buy rating on the shares. ARGUS CUTS CBS TO HOLD: Argus analyst Joseph Bonner downgraded CBS (CBS) to Hold from Buy, noting significant downside risks for the company from both the sexual harassment allegations against CEO Moonves and the board's attempts to prevent the Viacom (VIA, VIAB) merger. Bonner noted that if the Moonves allegations are proven true, he would be immediately dismissed, which could end the board's bid to remain independent and thereby inflict damage on the shareholders.
08/07/18
MSCO
08/07/18
NO CHANGE
Target $1325
MSCO
Overweight
Enterprise value of Alphabet's Waymo raised to $175B at Morgan Stanley
Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, namely logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Partnerships with Walmart (WMT), DDR (DDR) and Peterbilt speak to Waymo's logistics focus, said Nowak, who sees the company potentially having a $90B logistics business. Additionally, he sees a roughly $7B licensing opportunity, pointing to the company's FCA (FCAU) relationship as a model of how companies could pay a license fee to Waymo for its autonomous technology. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares.

TODAY'S FREE FLY STORIES

MU

Micron

$34.81

0.92 (2.71%)

, UMC

UMC

$1.81

-0.005 (-0.28%)

13:50
12/18/18
12/18
13:50
12/18/18
13:50
On The Fly
Fly Intel: What to watch for in Micron's earnings report »

Micron (MU) is scheduled…

MU

Micron

$34.81

0.92 (2.71%)

UMC

UMC

$1.81

-0.005 (-0.28%)

INTC

Intel

$48.04

0.95 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

VOD

Vodafone

$19.88

-0.13 (-0.65%)

13:48
12/18/18
12/18
13:48
12/18/18
13:48
Periodicals
Vodafone preparing to remove PwC as auditor, Sky News reports »

Vodafone is preparing to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

, GOOG

Alphabet

$1,046.01

28.41 (2.79%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Periodicals
Search engine startup claims Google still blocking competition, TechCrunch says »

The European Commission…

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

GOOG

Alphabet

$1,046.01

28.41 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

KMX

CarMax

$60.38

0.11 (0.18%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Options
7X average daily option volume in CarMax driven by an earnings hedge »

7X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

  • 31

    Jan

  • 01

    Feb

BIDU

Baidu

$169.94

0.03 (0.02%)

13:35
12/18/18
12/18
13:35
12/18/18
13:35
Hot Stocks
Unity Technologies, Baidu partner to develop autonomous vehicle simulation »

Unity Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$131.11

2 (1.55%)

13:32
12/18/18
12/18
13:32
12/18/18
13:32
Periodicals
J&J settles woman's talc cancer case for over $1.5M, Bloomberg reports »

Johnson & Johnson,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

ORGS

Orgenesis

$4.84

-0.11 (-2.22%)

13:31
12/18/18
12/18
13:31
12/18/18
13:31
Hot Stocks
Orgenesis announces collaboration with MangoGen Pharma »

Orgenesis announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNN

Smith & Nephew

$36.67

-0.38 (-1.03%)

13:27
12/18/18
12/18
13:27
12/18/18
13:27
Hot Stocks
Smith & Nephew buys Ceterix Orthopaedics for $50M initial consideration »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$81.62

1.12 (1.39%)

13:26
12/18/18
12/18
13:26
12/18/18
13:26
Hot Stocks
Albemarle higher after Hedgeye names new Best Idea Long »

Shares of Albemarle are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$104.09

1.87 (1.83%)

, ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

13:24
12/18/18
12/18
13:24
12/18/18
13:24
On The Fly
Game On: Wedbush's Pachter says 'Red Dead 2' performing better than he expected »

SUCCESS OF 'RED DEAD 2':…

TTWO

Take-Two

$104.09

1.87 (1.83%)

ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

EA

Electronic Arts

$81.22

2.01 (2.54%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$104.06

1.08 (1.05%)

SNE

Sony

$50.06

-0.425 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 03

    Mar

  • 04

    Mar

13:20
12/18/18
12/18
13:20
12/18/18
13:20
Options
Put buying in PHLX Gold and Silver Mining Index as the sector sees strength »

Put buying in PHLX Gold…

APHA

Aphria

$5.98

0.54 (9.93%)

13:18
12/18/18
12/18
13:18
12/18/18
13:18
Hot Stocks
Citron expects 'major partnership or total buyout' soon for Aphria 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.01

0.57 (10.48%)

, IGC

India Globalization Capital

$0.00

(0.00%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Hot Stocks
Citron mentions Aphria positively again, says 'everything changed' in cannabis 

Reference Link

APHA

Aphria

$6.01

0.57 (10.48%)

IGC

India Globalization Capital

$0.00

(0.00%)

CANN

General Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$29.00

-0.365 (-1.24%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

CRON

Cronos Group

$11.64

0.52 (4.68%)

TLRY

Tilray

$74.39

8.5 (12.90%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

ACB

Aurora Cannabis

$5.55

0.01 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.01

0.57 (10.48%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Periodicals
Breaking Periodicals news story on Aphria »

Citron Research sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/18/18
12/18
13:16
12/18/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$24.98

-0.32 (-1.26%)

13:15
12/18/18
12/18
13:15
12/18/18
13:15
Options
Nielsen put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$12.56

-1.89 (-13.08%)

13:14
12/18/18
12/18
13:14
12/18/18
13:14
Hot Stocks
Vintage says Rent-A-Center termination invalid, sees merger pact as in effect »

Vintage Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

RCII

Rent-A-Center

$12.67

-1.78 (-12.32%)

13:13
12/18/18
12/18
13:13
12/18/18
13:13
Hot Stocks
Breaking Hot Stocks news story on Rent-A-Center »

Vintage Capital believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

RCII

Rent-A-Center

$12.67

-1.78 (-12.32%)

13:12
12/18/18
12/18
13:12
12/18/18
13:12
Hot Stocks
Breaking Hot Stocks news story on Rent-A-Center »

Vintage Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

ISCA

International Speedway

$43.26

0.12 (0.28%)

13:10
12/18/18
12/18
13:10
12/18/18
13:10
Periodicals
Billionaire John Henry interested in Nascar stake, Bloomberg reports »

Billionaire and Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:10
12/18/18
12/18
13:10
12/18/18
13:10
General news
FOMC began its 2-day meeting amid myriad controversies »

FOMC began its 2-day…

RCII

Rent-A-Center

$12.72

-1.73 (-11.97%)

13:09
12/18/18
12/18
13:09
12/18/18
13:09
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

CSCO

Cisco

$44.25

0.04 (0.09%)

, AAOI

Applied Optoelectronics

$16.24

-0.89 (-5.20%)

13:05
12/18/18
12/18
13:05
12/18/18
13:05
Recommendations
Cisco, Applied Optoelectronics, Finisar analyst commentary  »

Luxtera buyout negative…

CSCO

Cisco

$44.25

0.04 (0.09%)

AAOI

Applied Optoelectronics

$16.24

-0.89 (-5.20%)

FNSR

Finisar

$21.76

0.2 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 04

    Mar

APHA

Aphria

$5.87

0.43 (7.90%)

13:05
12/18/18
12/18
13:05
12/18/18
13:05
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.